Stock CRDF CARDIFF ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.07 USD +2.01% Intraday chart for Cardiff Oncology, Inc. -6.44% +175.00%
Apr. 08 Cardiff Oncology Presents Novel Preclinical Data At Aacr Annual Meeting 2024 That Supports Ongoing First-Line Ras-Mutated Mcrc Clinical Study CI
Mar. 06 HC Wainwright Adjusts Price Target on Cardiff Oncology to $14 From $12, Keeps Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CRDF Stock
  4. Revisions Cardiff Oncology, Inc.